Come up with a name for your new list and we'll add to it:
Apellis Pharmaceuticals raised a round of funding on November 24, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company, focused on the development of a platform of novel therapeutic compounds for the treatment of a broad range of autoimmune diseases…